Abnormal Genitalia/ Disorders of Sex Development Panel

The Blueprint Genetics Abnormal Genitalia/ Disorders of Sex Development Panel is a 39 gene diagnostic tool developed for patients with clinical suspicion of androgen insensitivity syndrome, congenital adrenal hyperplasia, female pseudohermaphroditism, indeterminate sex and pseudohermaphroditism or male pseudohermaphroditism.

Clinical Research Prenatal Carrier

Test Details
Disorder◦ Androgen Insensitivity Syndrome
◦ Congenital Adrenal Hyperplasia
Type◦ Molecular
◦ Multi-Method Panel
◦ Multi-Gene Panel
Method◦ Del/Dup (CNV)
◦ Sequencing, Next Gen
GenesAMH, AMHR2, ANOS1, AR, ARX, ATRX, BCOR, CDKN1C, CEP41, CHD7, CREBBP, CYP11B1, CYP17A1, CYP19A1, CYP21A2, DHCR7, DYNC2H1, FIG4, FRAS1, GATA4, GNRHR, HSD17B3, HSD3B2, IL17RD, IRF6, LHCGR, MKS1, NR0B1, NR5A1, POR, PROKR2, RSPO1, SOX9, SRD5A2, SRY, STAR, TACR3, WT1, ZFPM2
Ordering
Test CodeEN0201
Test URLhttp://endocrinology.blueprintgenetics.com/panels/abnormal-genitalia-disorders-of-sex-development-panel/
Turnaround Time3-4 weeks
Preferred SpecimenEDTA blood, min. 1 ml
Alternate SpecimenPurified DNA, min. 5 ug. Saliva (Oragene DNA OG-500 kit)
Shippinghttp://blueprintgenetics.com/faqs/#shipping
Billing
Billing InfoInvoices are sent when clinical statement of the genetic test is available for the customer. Please visit http://blueprintgenetics.com/faqs/#invoicing for more details.
ICD-10◦ E250 - Congenital adrenogenital disorders associated with enzyme deficiency
◦ Q561 - Male pseudohermaphroditism, not elsewhere classified
◦ Q562 - Female pseudohermaphroditism, not elsewhere classified
New York Approved
 

Laboratory

Blueprint Genetics, San Francisco
1250 Missouri Street, #208
San Francisco
CA 94107
USA

email: support.us@blueprintgenetics.com

Lab Details

 

Follow GeneTests

 

Share

Write a comment ...
Post Comment
Cancel